Olive AI is the latest digital health “unicorn” to go out of business, but industry insiders say it won’t be the last. Investors say more failures are on the horizon as the industry continues to adjust to a different economic environment. “I think we’re going to be in for more news like this over the next 18 to 24 months until everything gets right-sized,” said Keith Figlioli, managing partner at venture capital company LRVHealth, an investor in Olive. “That’s what we’ve been saying to our investor base and all of our companies for over a year now. I’m not shocked by any of it.”
Read the full article: Olive AI’s Failure: Digital Health Investors Predict What’s Next //
Source: https://www.modernhealthcare.com/digital-health/olive-ai-shutting-down-digital-health-investors-waystar-humata